Genomics Research and Development Institute - Romania

Name

Genomics Research and Development Institute - Romania

Legal name

Institutul de Cercetare-Dezvoltare în Genomică

Website

https://genomica.gov.ro

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Genomics Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)

akta.pro secondary industries

Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

Keywords

• Genomics research services
• Next-generation sequencing
• Bioinformatics analysis
• Genomic medicine research
• Precision medicine programs

Headquarters

HQ city

Bucharest

HQ country

Romania

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Public Research Funding: As a public national research institute under the University of Medicine and Pharmacy 'Carol Davila' Bucharest, ICDG operates on government and EU funding. Major funded projects include ROGEN (85M EUR total, 18M EUR for ICDG), Equitable Genetics (~8.5M EUR total, ~6.5M EUR coordinated by ICDG), and EXCELY (30M EUR, ~4.7M EUR for ICDG). Funding sources include EU4Health, Europa Digitală, and national research programs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

ICDG is Romania's national genomics and genomic medicine research institute. It conducts advanced genomics research using next-generation sequencing, whole genome sequencing, nanopore long-read sequencing, spatial transcriptomics, AI-based bioinformatics analysis, and biobanking. It coordinates national and European genomics initiatives (1+MG, GDI, Genome of Europe) and runs programs such as "Genetică Echitabilă" to provide equitable access to genetic testing across Romania. The institute also delivers hands-on educational workshops and training programs in NGS, WGS, and bioinformatics in partnership with UMF Carol Davila and international collaborators.

Product overview

The Genomics Research and Development Institute (ICDG) operates as Romania's national research institute for genomics and genomic medicine. The organization provides whole genome sequencing services and bioinformatics analysis capabilities through international collaborations. Its portfolio includes the 'Genetică Echitabilă' national equitable-access genetic testing program, along with educational programs and hands-on workshops in genomic technologies. The institute coordinates multiple European projects including Genome of Europe, GDI, and ROGEN, positioning it as a central hub for genomic research infrastructure in Romania rather than a commercial product company.

Differentiator

Problem solved

Functional benefit

Products and services

• Genomic Research and Sequencing Services
• Genetică Echitabilă (Equitable Genetics) National Program
• Educational Programs and Hands-On Workshops

Quantifiable outcome

• Romania recognized for progress in genomics 6 months after joining the 1+ Million Genomes initiative.
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Partnerships

Eleven partnerships are on record, tiered minor and core.

• National Alliance for Rare Diseases RomaniaminorStrategic or Co-development Partner · 1 February 2025Co-organizer of the National Rare Disease Day Conference 2025 alongside UMF Carol Davila and ICDG, bringing together patients and specialists.
• Genome of Europe (GoE)coreStrategic or Co-development Partner · 1 December 2024ICDG officially participates in the Genome of Europe project, which aims to create the first European reference genome by early 2028. Romania joined Cyprus, Hungary, and Malta in the GoE initiative in 2024.
• University of Southern California, deCODE Genetics (Iceland), Hartwig Medical Foundation (Netherlands)coreStrategic or Co-development Partner · 1 November 2024International bioinformatics partners for the hands-on bioinformatics data analysis workshop series. deCODE Genetics and Hartwig Medical Foundation provided expert lecturers for genomic data analysis training in Romania.
• RoHealth (Romanian Health Cluster)minorGTM or Marketing Partner · 1 November 2024ICDG participated in the BeHealth and Digital 2024 international hybrid event organized by ROHEALTH, the Romanian Health Cluster, which brings together health innovation stakeholders.
• University of Medicine and Pharmacy 'Carol Davila' Bucharest (UMFCD)coreStrategic or Co-development Partner · 24 October 2024ICDG operates under the administrative umbrella of UMFCD Bucharest. The two institutions collaborate extensively on education (workshops, hands-on training in NGS and bioinformatics), research projects, and the national genomics strategy. Joint workshops on NGS sequencing, bioinformatics, and genomic technologies are regularly organized.
• Johns Hopkins University (USA)coreStrategic or Co-development Partner · 24 October 2024Collaboration on AI-based liquid biopsy research using cell-free DNA fragmentomes. Prof. Victor E. Velculescu, faculty at Johns Hopkins, serves as President of ICDG's Advisory Council and supports ICDG's development. Validation of AI-based early cancer detection technology ongoing with ICDG, UMFCD, and Fundeni Clinical Institute.
• Victor Babeș National Institute of PathologycoreStrategic or Co-development Partner · 1 September 2024Collaborates with ICDG on whole genome sequencing implementation in Romania. Together with UMFCD, forms the core Romanian consortium for pilot WGS studies and international collaboration.
• Germany, Bulgaria, Greece (pilot WGS partners)minorStrategic or Co-development Partner · 1 September 2024European country partners in the pilot whole genome sequencing study coordinated by ICDG. Romania is piloting WGS implementation with support from these countries.
• ROGEN ConsortiumcoreStrategic or Co-development Partner · 1 September 2024Development of Genomics Research in Romania (ROGEN) project with budget of 85M EUR (ICDG: 18M EUR). Multi-institutional Romanian consortium coordinated by UMFCD for building national genomics research capacity.
• Genomic Data Infrastructure (GDI) ConsortiumcoreStrategic or Co-development Partner · 12 April 2024Romania formally joined the GDI project coordinated by the European Commission. ICDG is the primary implementing institution for GDI in Romania, co-funded by the Europa Digitală program, as part of the 1+MG initiative.
• University College London, Queen Mary University London, and Genomics EnglandcoreStrategic or Co-development Partner · 28 January 2024ICDG conducted an institutional visit to UCL, Queen Mary University London, and held a meeting with Genomics England to explore collaboration opportunities and learn from UK genomic infrastructure experience.

Scale indicators6 records

Recent moves12 records

Expansion highlights6 records

Broad incumbents

• Eurofins Genomics: Commercial provider of genomic services across Europe including NGS, WGS, and bioinformatics. Broad incumbent offering comparable commercial sequencing services that could compete with or complement ICDG's national program in adjacent markets.
• Illumina: Dominant global provider of NGS and WGS sequencing platforms and consumables. ICDG's leadership visited Illumina Cambridge to explore technology partnerships, and Illumina's technology underlies ICDG's sequencing infrastructure, making it a foundational incumbent in the value chain.
• BGI Genomics: China-based global leader in genomic sequencing services with significant European presence. Broad incumbent that competes at the scale of national genomic infrastructure projects and provides alternative sequencing/plaform capabilities to ICDG's stack.

Direct peers

• European Bioinformatics Institute (EMBL-EBI): EMBL-affiliated bioinformatics and genomic data infrastructure provider central to the GDI and 1+MG initiatives. ICDG engages with EBI through European genomic data projects, making it a direct peer in genomic data infrastructure and multi-omics analysis.
• deCODE Genetics: Icelandic population-genomics company (Amgen subsidiary) that performs large-scale human genetic analysis and provided expert lecturers for ICDG's bioinformatics workshop. Direct peer because of its pioneering role in national-scale genomic sequencing and population genomics research.
• Hartwig Medical Foundation: Dutch whole-genome sequencing initiative for cancer patients that also contributed expert lecturers to ICDG's bioinformatics workshops. Comparable as a national-scale clinical genomics infrastructure with international research collaboration.
• Genomics England: UK government-owned genomic medicine initiative running the 100,000 Genomes Project and national NHS genomic medicine service. ICDG conducted an institutional visit to Genomics England to learn from its genomic infrastructure experience, making it a closest structural peer as a national genomic medicine program.

Regional players

• Centro Nacional de Análisis Genómico (CNAG): Spain's national center for large-scale genomic sequencing, part of the Centre for Genomic Regulation. Direct peer as a national-scale sequencing and bioinformatics facility supporting European genomic research projects.
• Finnish Institute for Molecular Medicine (FIMM): University of Helsinki-affiliated molecular medicine institute that integrates genomic, clinical, and biobank data for precision medicine. Comparable as a Northern European national R&D institute combining multi-omics research with clinical translation.
• Estonian Genome Centre (University of Tartu): Estonian national biobank and genomics research center at University of Tartu. Closest geographic and structural peer to ICDG as a small EU member state running a national genomic medicine program integrated into European genomic data infrastructure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/genomica.gov.ro
• LinkedInlinkedin.com/company/genomica-gov-ro

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genomics Research and Development Institute - Romania